Cerebral will stop prescribing most controlled substances to new and existing patients, the embattled digital mental health company confirmed to Insider.
According to an email sent to staff on Monday, Cerebral CEO Kyle Robertson said the company would halt prescriptions of controlled substances like Adderall and Xanax for new patients starting May 20 and for existing patients starting October 15...
Demand for mental health services has soared since the COVID-19 pandemic. In the UK alone an estimated 1.6 million people are awaiting treatment, while a further eight million who do not qualify for NHS help are experiencing day-to-day challenges.
Increasingly digital therapeutics (DTx) are being considered as an option to fill the gaps in healthcare provision. They have the potential to be woven...
A combined approach using both face-to-face screenings and a machine learning model embedded in an EHR performed best at predicting suicide risk among adults, according to a study published in JAMA Network Open.
The study included more than 120,000 encounters in inpatient, ambulatory surgical and emergency department settings from more than 83,000 patients. It found the hybrid approach that used...
Free mental health app available to 1 million South Yorkshire NHS users
An emotional wellness app is being offered to over 16s in the UK's South Yorkshire for free, to help manage low moods, reduce stress and improve sleep.
The myStrength app has been commissioned by the South Yorkshire Integrated Care System (ICS) and is being delivered by Consultant Connect, part of the Teladoc Group.
Users are...
Mental health EHR Osmind scored $40 million in a Series B funding round led by DFJ Growth.
Other participants include Susa Ventures, General Catalyst, Future Ventures, Tiger Global, Pear VC and angels Lachy Groom, Brent Saunders, Helena Goodman and Ariel Katz.
Osmind offers an EHR tailored to clinicians and researchers using and studying ketamine and other psychedelics, as well as transcranial...
Cerebral is under investigation for possible violations of the Controlled Substances Act as the digital mental health company faces increasing scrutiny over its prescribing practices for medications like Adderall.
As first reported by Insider, Cerebral confirmed it had received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York on the evening of May 4. That...
Editor's note: This story has been updated to reflect that Cerebral does not offer services to patients under the age of 18.
BOSTON – Cerebral Chief Medical Officer Dr. David Mou on Sunday defended the digital mental health company's prescribing practices, but mistakes have been made, especially in the area of marketing, he admitted during the American Telemedicine Association Association's...
Behavioral health startup Concert Health wrapped up a $42 million Series B funding round led by Define Ventures.
Other participants in the round include Healthy Ventures, Vertical Venture Partners and Townhall Ventures, as well as strategic investors CommonSpirit Health and Advent Health. Concert scored $14 million in Series A financing in January 2021.
WHAT IT DOES
The startup works with...
Virtual mental healthcare provider Iris Telehealth scooped up $40 million in a Series B funding led by Concord Health Partners and Columbia Pacific Advisors.
WHAT IT DOES
Iris provides telepsychiatry services through partnerships with providers like health systems, hospitals and community health centers. The company can also help its provider clients triage patients who need more advanced mental...
Providing video-enabled tablets to rural veterans decreased emergency department visits and suicide behaviors, and increased both in-person and virtual mental health visits, according to a study published in JAMA Network Open.
"These findings suggest that video-enabled tablets may provide access to critical services for rural patients with mental health needs and reduce instances of suicide...